Xiong W, Wang D, Han F, Yamashita Y, et al. Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial. Thromb Haemost 2026 May 15. doi: 10.1055/a-2868-2803.
PMID: 42140238